JNK and ATF4 as two important platforms for tumor necrosis factor-α-stimulated shedding of receptor for advanced glycation end products.
Miyoshi A, Koyama S, Sasagawa-Monden M, Kadoya M, Konishi K, Shoji T, Inaba M, Yamamoto Y, Koyama H.
Miyoshi A, et al. Among authors: konishi k.
FASEB J. 2019 Mar;33(3):3575-3589. doi: 10.1096/fj.201701553RR. Epub 2018 Nov 19.
FASEB J. 2019.
PMID: 30452882
-Miyoshi, A., Koyama, S., Sasagawa-Monden, M., Kadoya, M., Konishi, K., Shoji, T., Inaba, M., Yamamoto, Y., Koyama, H. JNK and ATF4 as two important platforms for tumor necrosis factor-alpha-stimulated shedding of receptor for advanced glycation end products....
-Miyoshi, A., Koyama, S., Sasagawa-Monden, M., Kadoya, M., Konishi, K., Shoji, T., Inaba, M., Yamamoto, Y., Koyama, H. JNK and …